Cognitive Stimulation for Elderly Bipolar Patients

NCT ID: NCT04184375

Last Updated: 2025-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-04

Study Completion Date

2026-09-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bipolar disorders, which belong to the category of mood disorders, are the 6th leading cause of disability in the world. Cognitive disorders are known to exist during the phases of bipolar disease, and alterations increase significantly after the age of 65. Recent studies have shown that attention, memory and executive function impairments are the main causes of cognitive disorders. Residual symptoms have a significant impact on the risk of relapse into bipolar disorder and on quality of life. Cognitive stimulation (CS) is a pedagogical approach based on the idea that cognitive skills contribute to personal development in the same way as psychological and social factors. This study aims at assessing a cognitive stimulation program initially developed for patients with neurodegenerative diseases, and adapted to bipolar disease. This program will be compared to the usual practice consisting in consultation with psychiatrist and sometimes in intervention of home nurses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder Cognitive Impairment Age-related Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TONIC

The cognitive stimulation sessions are carried out using Liliane Israël's "TRAIN YOUR MEMORY" software, and are divided into two parts: the first part is essentially cognitive and the second relates to the daily life of the Bipolar patient.

This training method consists of combining two means of intervention, pedagogical action and psychotherapeutic effect. It aims to stimulate, develop and strengthen the basic mechanisms underlying memory phenomena (sensory acuity, attention, associations, structuring, executive functions, spatial and temporal landmarks, associative recruitment). It is presented in the form of exercises divided into eight modules.

Group Type EXPERIMENTAL

cognitive stimulation

Intervention Type BEHAVIORAL

Patients participate in one session per week according to the following schedule:

* 2 sensory stimulation sessions: identify sensations, emotions, how to manage them.
* 2 sessions on association, verbal fluency, and imagination: language as a tool for expression in the face of illness.
* 2 voluntary attention sessions: improve daily attention.
* 2 sessions of intellectual structuring: stimulating and maintaining memory, carrying out external activities.
* 2 sessions of structuring through language: impact on social life.
* 2 sessions stimulating the temporal and spatial landmarks: agenda, daily trips.

Control

The usual practice consists of interviews with the psychiatrist with the possibility of home visits by the nurse.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cognitive stimulation

Patients participate in one session per week according to the following schedule:

* 2 sensory stimulation sessions: identify sensations, emotions, how to manage them.
* 2 sessions on association, verbal fluency, and imagination: language as a tool for expression in the face of illness.
* 2 voluntary attention sessions: improve daily attention.
* 2 sessions of intellectual structuring: stimulating and maintaining memory, carrying out external activities.
* 2 sessions of structuring through language: impact on social life.
* 2 sessions stimulating the temporal and spatial landmarks: agenda, daily trips.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \> 65 years old
* Diagnosis of bipolar illness for more than 10 years
* Euthymic phase
* Understands and speaks French
* Free, informed and express consent


* Mild to moderate neuro-cognitive impairments (MMS Test : 16 ≤ score \< 26)

Exclusion Criteria

* Illiteracy
* Patient participating in other therapeutic workshops (e. g. psycho-geriatric day hospital care, etc.)
* Persons deprived of their liberty by a judicial or administrative decision
* Persons of full age who are subject to a legal protection measure
* Persons unable to consent
* Persons who are not members of or beneficiaries of a social security scheme
* Patient's refusal to participate in the study
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Hospitalier de la Rochelle Ré Aunis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pascale Puzos, MD

Role: STUDY_DIRECTOR

Groupe Hospitalier de la Rochelle Ré Aunis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Groupe Hospitalier de la Rochelle Ré Aunis

La Rochelle, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Caroline ALLIX-BEGUEC, Ph.D.

Role: CONTACT

+33 (0) 516 49 42 46

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pascale Puzos, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015/P05/095

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.